MyFinsight
Home
Blog
About
Contact
mreo: the balance sheet
Download
Download image
Property and equipment,
at cost
$1,221K
Research and development
incentives receivables
$1,015K
Prepaid expenses and
other current assets
$2,694K
Cash and cash
equivalents
$48,698K
Intangible assets, net
$643K
Operating lease right of
use assets, net
$378K
Property and equipment,
net
$174K
Total current assets
$52,407K
Less accumulated
depreciation
$1,047K
Total assets
$53,602K
Total liabilities and
shareholders' equity
$53,602K
Total shareholders'
equity
$46,598K
Total liabilities
$7,004K
Accumulated other
comprehensive loss
-$10,910K
Accumulated deficit
-$493,667K
Additional paid-in capital
$548,041K
Other non-current
liabilities
$652K
Warrant liabilities -
non-current
$336K
Total current
liabilities
$6,016K
Ordinary shares, par
value 0.003 per share...
$3,134K
Other current
liabilities
$622K
Operating lease
liabilities - current
$397K
Accrued expenses
$4,118K
Accounts payable
$879K
Back
Back
Balance Sheet
source: myfinsight.com
Mereo BioPharma Group plc (MREO)
Mereo BioPharma Group plc (MREO)